Figure 3From: Evaluating harm associated with anti-malarial drugs: a survey of methods used by clinical researchers to elicit, assess and record participant-reported adverse events and related data Questioning methods about health used to capture AE data in interventional studies (N = 39, 2 = not known). Back to article page